Energenesis Biomedical Co., Ltd. (TWSE: 6657) is an R&D-based company in Taiwan. Our experienced team pioneers the development of new drugs and research-use reagents. At Analytica 2024, Energenesis presents reagents and kits under the brand name Visual Protein.

Among our products are reagents for proteomic research, offering solutions for protein isolation, quantification, Western blotting, and gel staining. For cell research, we introduce innovative protein-free cell culture supplements designed for hybridoma cells, such as HybriMore Hybridoma Culture Supplement. This product increases cell survival rates after cell fusion and enhances cell growth in low serum or serum-free culture systems.

We are actively seeking opportunities to establish distributorships and engage in OEM partnerships. For more information about our products, please visit www.visualprotein.com.